John Harold Leaman, Chief Financial Officer at Aevi Genomic Medicine, holds 0.00 shares in Aevi Genomic Medicine (Ticker: GNMX), holds 6.94K shares in Impel Pharmaceuticals (Ticker: IMPLQ). Most recently, John Harold Leaman ― shares of Aevi Genomic Medicine on ― for an estimated value of ―.